SEC Comment Letter for CHINA MEDICINE CORP (CIK 0001328790) — Jun 28, 2005
CHINA MEDICINE CORP (CIK 0001328790)
Date: June 28, 2005 · CIK: 0001328790 · Accession: 0000000000-05-033145
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Mail Stop 3561 June 28, 2005
Mark Allen, President
Lounsberry Holdings III, Inc..
90 Grove Street, Suite 204
Ridgefield, CT 06877
Re: Lounsberry Holdings I, Inc.
File No. 0-51377
Lounsberry Holdings II, Inc.
File No. 0-51378
Lounsberry Holdings III, Inc.
File No. 0-51379
Registration Statements on Form 10-SB
Filed June 23, 2005
Dear Mr. Allen:
This is to advise you that we have reviewed only those
portions of the above registration statements that relate to the
disclosure type indicated in this letter and we have the following
comments.
Part I
Item 5. Directors, Executive Officers, Promoters, and Control
Persons, page 13
1. Disclose under appropriate caption, any prior blank check
experiences involving officers and directors of each company,
describing, in column format, the name of each blank check
company,
the date of registration, file number with the Commission, and the
current status of the company`s filings. Also, state whether any
acquisitions, business combinations, or mergers are pending, have
occurred and the current operating status of each.
.
Financial Statements
2. Include the Company`s financial statements in the registration
statement before the signature page.
No further review of your filing will be made at this time. You
are
requested to file an amendment on Form 10SB12G/A to include the
necessary information within fifteen business days, or inform the
staff prior to that time when the amendment will be made.
Other
We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filing reviewed by the staff to
be
certain that they have provided all information investors require
for
an informed decision. Since the company and its management are in
possession of all facts relating to a company`s disclosure, they
are
responsible for the accuracy and adequacy of the disclosure they
have
made.
In connection with responding to our comments, please
provide, in writing, a statement from the company acknowledging
that
* the company is responsible for the adequacy and accuracy of the
disclosure in the filings;
* staff comments or changes to disclosure in response to staff
comments do not foreclose the Commission from taking any action
with
respect to the filing; and,
* the company may not assert staff comments as a defense in any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
In addition, please be advised that the Division of
Enforcement has access to all information you provide to the staff
of
the Division of Corporation Finance in our review of your filing
or
in response to our comments on your filing.
*******
Please be advised that your registration statement will
automatically become effective 60 days after filing. Upon
effectiveness, you will become subject to the reporting
requirements
of the Securities Exchange Act of 1934, even if we have not
cleared
your
comments. Note that the NASD Bulletin Board will not accept your
listing until we have cleared all comments. In the event that it
appears that you will not be able to respond by the 60th day, you
may
wish to consider withdrawing your registration statement and
refiling when you have prepared a response to our comments. In
addition, should the filing become effective in its present form
the
Division would be required to consider what recommendation, if
any,
it should make to the Commission.
Please contact Goldie B. Walker at (202) 551-3234 or me at
(202)
551-3790 in regard to any questions pertaining to this letter.
Sincerely,
Michael E. Karney
Branch Chief (Legal)
Office of Emerging Growth Companies
Division of Corporation Finance
??
??
??
??
Mark Allen, President
Lounsberry Holdings III, Inc.
June 28, 2005
Page 3
</TEXT>
</DOCUMENT>